CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging
Tao Zhang,1 Ping Zhang,2 Hong-Xia Li3 1Department of Tuberculosis, Linyi People’s Hospital, Linyi, Shandong 276034, People’s Republic of China; 2Reproductive Medicine, Linyi People’s Hospital, Linyi, Shandong 276034, People’s Republic of China; 3Endoscopic Roo...
Enregistré dans:
Auteurs principaux: | Zhang T, Zhang P, Li HX |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b1f66b24f35d48e7b519b001bbb9392f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development
par: Kok VC, et autres
Publié: (2020) -
Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer
par: Zhang Q, et autres
Publié: (2020) -
Exosomal miRNAs and lncRNAs: The Modulator Keys of Cancer-Associated Fibroblasts in the Genesis and Progression of Malignant Neoplasms
par: Julio César Villegas-Pineda, et autres
Publié: (2021) -
Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy
par: Ma Y, et autres
Publié: (2019) -
Inhibition of Circulating Exosomal miRNA-20b-5p Accelerates Diabetic Wound Repair
par: Chen K, et autres
Publié: (2021)